drugset / Trial / NCT00746252

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder

NCT00746252 ↗

Terminated 5 enrolled University of Maryland, Baltimore
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to learn more about weight gain and related side effects when children are treated with antipsychotic medicine for mood disorders.

Timeline

Start
2008-06
Primary completion
2010-10
Completion
2010-10

Outcome

Missed primary endpoint

Stopped (Business): “Due low rate of participation and lack of funding”

registry MEAN Risperidone: 8.5 (Standard Deviation NA) pounds MEAN Aripiprazole: 6.65 (Standard Deviation 1.48) pounds NCT00746252 ↗

registry analysis (other test); Risperidone vs Aripiprazole; p = .495; t-test, 2 sided; note: Threshold of significance is p\<.05 NCT00746252 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified — —
Subject Risperidone Other / unclassified — —

Indications